Investing Profile

Marianne Mertens

InvestorVC
Partner at Apollo Health Ventures
Photo of Marianne Mertens, Partner at Apollo Health Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
WHU – Otto Beisheim School of Management Network
69 CONNECTIONS
RWTH Aachen University Network
28 CONNECTIONS
RWTH Aachen University Network
28 CONNECTIONS
RWTH Aachen University Network
28 CONNECTIONS
RWTH Aachen University Network
28 CONNECTIONS
cb
$100K - $5.0M
$1.5M
5
CompanyStageDateRound SizeTotal Raised
Scripta Therapeutics
SeedNov 2025$12M
$12M
Co-investors: Claire Brown (Oxford Science Enterprises)
Auron Therapeutics
Series BFeb 2025$27M
Series AJul 2022$48M
$88M
Co-investors: Alexandra Cantley (Polaris Partners), Eric Shiozaki (Revelation Partners), Daniel Coley (Cofounders Capital), Isaac Ciechanover
Booster Therapeutics
SeedOct 2024$15M
$15M
Cleara Biotech
SeedSep 2022$3M
$3M
Co-investors: Viktoriya Tigipko (TA Ventures)
Principal Wellington PartnersPresent
Board Director Cleara Biotech B.V.Present
Board Observer Auron Therapeutics, Inc.Present
Managing Director and Board Director Booster TherapeuticsPresent
Board Director HAYA TherapeuticsPresent
Board Observer Aeovian PharmaceuticalsPresent
Investor Therini Bio, Inc.Present
Board Director Scripta TherapeuticsPresent
Investment Committee Member Alzheimer's Drug Discovery FoundationPresent
Partner Apollo Health VenturesPresent
RWTH Aachen University Bachelor of Science (B.Sc.), Master of Science (M.Sc.) Biotechnology
RWTH Aachen University Bachelor of Science (B.Sc.) Master of Science (M.Sc.), Biotechnology
RWTH Aachen University Dr. rer. nat., Biotechnology Experimental Molecular Imaging
RWTH Aachen University Dr. rer. nat., Biotechnology Molecular Imaging and Medicine
RWTH Aachen University Dr. rer. nat. Biotechnology, Molecular Imaging and Medicine
WHU – Otto Beisheim School of Management Executive Education Value Creation in Private Equity and Venture Capital
Sign in with Google →
Sign in with Google →